Skip to main content

Table 1 Clinical characteristics of AML patients and a reference group

From: Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia

AML Patients (n = 49)

FAB

Subtype

Number of patients

Age

Sex

F/M

AML M0

2

53 ± 0

2/0

AML M1

6

57.5 ± 19.25

5/1

AML M2

15

58.8 ± 15.53

8/7

AML M4

8

70.25 ± 12.89

5/3

AML M5

4

63 ± 20.92

2/2

AML M5b

5

62.8 ± 9.4

2/3

AML/MDS

9

59.44 ± 11.51

4/5

All patients

49

61.14 ± 15.07

28/21

Reference group (n = 51)

Control group

51

58.68 ± 19.77

24/27